Multi-Modal Spatial Omics Platforms Market Key Players Analysis 2025 to 2034

Report Id: 3243 Pages: 180 Last Updated: 17 December 2025 Format: PDF / PPT / Excel / Power BI
Share With : linkedin twitter facebook

Segmentation of the Multi-Modal Spatial Omics Platforms Market:

Global Multi-Modal Spatial Omics Platforms Market- By Multi-Omic Combination

·       RNA + Protein

·       Protein + Metabolite/Lipid

·       RNA + DNA / Genomic features

·       Tri-modal (RNA + Protein + Morphology/Metabolite)

Multi-Modal Spatial Omics Platforms Market seg

Global Multi-Modal Spatial Omics Platforms Market – By Detection Modality

·       In situ imaging (cyclic IF, fluorescence)

·       In situ hybridization / in situ sequencing

·       ROI-based digital spatial profiling

·       Imaging mass cytometry/ion beam imaging

·       Barcoding-based spatial transcriptomics

Global Multi-Modal Spatial Omics Platforms Market – By Workflow Component

·       Instruments/Platforms

·       Reagents & Panels

·       Software/Analytics

·       Services/CROs

Global Multi-Modal Spatial Omics Platforms Market- By Sample Type

·       FFPE

·       Fresh Frozen

·       Organoids / Cells

Global Multi-Modal Spatial Omics Platforms Market – By Spatial Resolution

·       Subcellular

·       Single-cell

·       Spot-level / ROI

Global Multi-Modal Spatial Omics Platforms Market – By Multiplexing Capacity

·       Low-plex (< 100 targets)

·       Mid-plex (100 – 1,000 targets)

·       High-plex (> 1,000 targets or whole-transcriptome)

Global Multi-Modal Spatial Omics Platforms Market – By Application

·       Immuno-oncology / Tumor Microenvironment

·       Biomarker discovery

·       Neuroscience

·       Inflammation & Autoimmune

·       Infectious Diseases

·       Fibrosis

Global Multi-Modal Spatial Omics Platforms Market – By End-User

·       Pharma & Biotech

·       Academic & Research Institutes

·       CROs & Service Providers

·       Hospitals & Pathology Labs

Global Multi-Modal Spatial Omics Platforms Market – By Region

North America-

·       The US

·       Canada

Europe-

·       Germany

·       The UK

·       France

·       Italy

·       Spain

·       Rest of Europe

Asia-Pacific-

·       China

·       Japan

·       India

·       South Korea

·       Southeast Asia

·       Rest of Asia Pacific

Latin America-

·       Brazil

·       Argentina

·       Mexico

·       Rest of Latin America

 Middle East & Africa-

·       GCC Countries

·       South Africa

·       Rest of the Middle East and Africa

Chapter 1.    Methodology and Scope

1.1.    Research Methodology
1.2.    Research Scope & Assumptions

Chapter 2.    Executive Summary

Chapter 3.    Global Multi-Modal Spatial Omics Platforms Market Snapshot

Chapter 4.    Global Multi-Modal Spatial Omics Platforms Market Variables, Trends & Scope

4.1.    Market Segmentation & Scope
4.2.    Drivers
4.3.    Challenges
4.4.    Trends 
4.5.    Investment and Funding Analysis 
4.6.    Porter's Five Forces Analysis
4.7.    Incremental Opportunity Analysis (US$ MN), 2024-2034 
4.8.    Competitive Landscape & Market Share Analysis, By Key Player (2023)
4.9.    Use/impact of AI on Multi-Modal Spatial Omics Platforms Market Industry Trends 
4.10.    Global Multi-Modal Spatial Omics Platforms Market Penetration & Growth Prospect Mapping (US$ Mn), 2021-2034

Chapter 5.    Multi-Modal Spatial Omics Platforms Market Segmentation 1: By Multi-Omic Combination, Estimates & Trend Analysis

5.1.    Market Share by Multi-Omic Combination, 2024 & 2034
5.2.    Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Multi-Omic Combination:

5.2.1.    RNA + Protein
5.2.2.    Protein + Metabolite/Lipid
5.2.3.    RNA + DNA / Genomic features
5.2.4.    Tri-modal (RNA + Protein + Morphology/Metabolite)    

Chapter 6.    Multi-Modal Spatial Omics Platforms Market Segmentation 2: By Detection Modality, Estimates & Trend Analysis

6.1.    Market Share by Detection Modality, 2024 & 2034
6.2.    Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Detection Modality:

6.2.1.    In situ imaging (cyclic IF, fluorescence)
6.2.2.    In situ hybridization / in situ sequencing
6.2.3.    ROI-based digital spatial profiling
6.2.4.    Imaging mass cytometry/ion beam imaging
6.2.5.    Barcoding-based spatial transcriptomics     

Chapter 7.    Multi-Modal Spatial Omics Platforms Market Segmentation 3: By Workflow Component, Estimates & Trend Analysis

7.1.    Market Share by Workflow Component, 2024 & 2034
7.2.    Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Workflow Component:

7.2.1.    Instruments/Platforms
7.2.2.    Reagents & Panels
7.2.3.    Software/Analytics
7.2.4.    Services/CROs          

Chapter 8.     Multi-Modal Spatial Omics Platforms Market Segmentation 4: By Sample Type, Estimates & Trend Analysis

8.1.    Market Share by Sample Type, 2024 & 2034
8.2.    Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Sample Type:

8.2.1.    FFPE
8.2.2.    Fresh Frozen
8.2.3.    Organoids / Cells

Chapter 9.    Multi-Modal Spatial Omics Platforms Market Segmentation 5: By Spatial Resolution, Estimates & Trend Analysis

9.1.    Market Share by Spatial Resolution, 2024 & 2034
9.2.    Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Spatial Resolution:

9.2.1.    Subcellular
9.2.2.    Single-cell
9.2.3.    Spot-level / ROI

Chapter 10.    Multi-Modal Spatial Omics Platforms Market Segmentation 6: By Multiplexing Capacity, Estimates & Trend Analysis

10.1.    Market Share by Multiplexing Capacity, 2024 & 2034
10.2.    Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Multiplexing Capacity:

10.2.1.    Low-plex (< 100 targets)
10.2.2.    Mid-plex (100 – 1,000 targets)
10.2.3.    High-plex (> 1,000 targets or whole-transcriptome)

Chapter 11.    Multi-Modal Spatial Omics Platforms Market Segmentation 7: By Application, Estimates & Trend Analysis

11.1.    Market Share by Application, 2024 & 2034
11.2.    Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Application:

11.2.1.    Immuno-oncology / Tumor Microenvironment
11.2.2.    Biomarker discovery
11.2.3.    Neuroscience
11.2.4.    Inflammation & Autoimmune
11.2.5.    Infectious Diseases
11.2.6.    Fibrosis

Chapter 12.    Multi-Modal Spatial Omics Platforms Market Segmentation 8: By End-User, Estimates & Trend Analysis

12.1.    Market Share by End-User, 2024 & 2034
12.2.    Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following End-User:

12.2.1.    Pharma & Biotech
12.2.2.    Academic & Research Institutes
12.2.3.    CROs & Service Providers
12.2.4.    Hospitals & Pathology Labs

Chapter 13.    Multi-Modal Spatial Omics Platforms Market Segmentation 9: Regional Estimates & Trend Analysis

13.1.    Global Multi-Modal Spatial Omics Platforms Market, Regional Snapshot 2024 & 2034

13.2.    North America

13.2.1.    North America Multi-Modal Spatial Omics Platforms Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034

13.2.1.1.    US
13.2.1.2.    Canada

13.2.2.    North America Multi-Modal Spatial Omics Platforms Market Revenue (US$ Million) Estimates and Forecasts by Multi-Omic Combination, 2021-2034
13.2.3.    North America Multi-Modal Spatial Omics Platforms Market Revenue (US$ Million) Estimates and Forecasts by Detection Modality, 2021-2034
13.2.4.    North America Multi-Modal Spatial Omics Platforms Market Revenue (US$ Million) Estimates and Forecasts by Workflow Component, 2021-2034
13.2.5.    North America Multi-Modal Spatial Omics Platforms Market Revenue (US$ Million) Estimates and Forecasts by Sample Type, 2021-2034
13.2.6.    North America Multi-Modal Spatial Omics Platforms Market Revenue (US$ Million) Estimates and Forecasts by Spatial Resolution, 2021-2034
13.2.7.    North America Multi-Modal Spatial Omics Platforms Market Revenue (US$ Million) Estimates and Forecasts by Multiplexing Capacity, 2021-2034
13.2.8.    North America Multi-Modal Spatial Omics Platforms Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
13.2.9.    North America Multi-Modal Spatial Omics Platforms Market Revenue (US$ Million) Estimates and Forecasts by End-User2021-2034

13.3.    Europe

13.3.1.    Europe Multi-Modal Spatial Omics Platforms Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034

13.3.1.1.    Germany
13.3.1.2.    U.K.
13.3.1.3.    France
13.3.1.4.    Italy
13.3.1.5.    Spain
13.3.1.6.    Rest of Europe

13.3.2.    Europe Multi-Modal Spatial Omics Platforms Market Revenue (US$ Million) Estimates and Forecasts by Multi-Omic Combination, 2021-2034
13.3.3.    Europe Multi-Modal Spatial Omics Platforms Market Revenue (US$ Million) Estimates and Forecasts by Detection Modality, 2021-2034
13.3.4.    Europe Multi-Modal Spatial Omics Platforms Market Revenue (US$ Million) Estimates and Forecasts by Workflow Component, 2021-2034
13.3.5.    Europe Multi-Modal Spatial Omics Platforms Market Revenue (US$ Million) Estimates and Forecasts by Sample Type, 2021-2034
13.3.6.    Europe Multi-Modal Spatial Omics Platforms Market Revenue (US$ Million) Estimates and Forecasts by Spatial Resolution, 2021-2034
13.3.7.    Europe Multi-Modal Spatial Omics Platforms Market Revenue (US$ Million) Estimates and Forecasts by Multiplexing Capacity, 2021-2034
13.3.8.    Europe Multi-Modal Spatial Omics Platforms Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
13.3.9.    Europe Multi-Modal Spatial Omics Platforms Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2021-2034

13.4.    Asia Pacific

13.4.1.    Asia Pacific Multi-Modal Spatial Omics Platforms Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034

13.4.1.1.    India 
13.4.1.2.    China
13.4.1.3.    Japan
13.4.1.4.    Australia
13.4.1.5.    South Korea
13.4.1.6.    Hong Kong
13.4.1.7.    Southeast Asia
13.4.1.8.    Rest of Asia Pacific

13.4.2.    Asia Pacific Multi-Modal Spatial Omics Platforms Market Revenue (US$ Million) Estimates and Forecasts by Multi-Omic Combination, 2021-2034
13.4.3.    Asia Pacific Multi-Modal Spatial Omics Platforms Market Revenue (US$ Million) Estimates and Forecasts by Detection Modality, 2021-2034
13.4.4.    Asia Pacific Multi-Modal Spatial Omics Platforms Market Revenue (US$ Million) Estimates and Forecasts Workflow Component, 2021-2034
13.4.5.    Asia Pacific Multi-Modal Spatial Omics Platforms Market Revenue (US$ Million) Estimates and Forecasts by Sample Type, 2021-2034
13.4.6.    Asia Pacific Multi-Modal Spatial Omics Platforms Market Revenue (US$ Million) Estimates and Forecasts by Spatial Resolution, 2021-2034
13.4.7.    Asia Pacific Multi-Modal Spatial Omics Platforms Market Revenue (US$ Million) Estimates and Forecasts by Multiplexing Capacity, 2021-2034
13.4.8.    Asia Pacific Multi-Modal Spatial Omics Platforms Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
13.4.9.    Asia Pacific Multi-Modal Spatial Omics Platforms Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2021-2034

13.5.    Latin America

13.5.1.    Latin America Multi-Modal Spatial Omics Platforms Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034

13.5.1.1.    Brazil
13.5.1.2.    Mexico
13.5.1.3.    Rest of Latin America

13.5.2.    Latin America Multi-Modal Spatial Omics Platforms Market Revenue (US$ Million) Estimates and Forecasts by Multi-Omic Combination, 2021-2034
13.5.3.    Latin America Multi-Modal Spatial Omics Platforms Market Revenue (US$ Million) Estimates and Forecasts by Detection Modality, 2021-2034
13.5.4.    Latin America Multi-Modal Spatial Omics Platforms Market Revenue (US$ Million) Estimates and Forecasts by Workflow Component, 2021-2034
13.5.5.    Latin America Multi-Modal Spatial Omics Platforms Market Revenue (US$ Million) Estimates and Forecasts by Sample Type, 2021-2034
13.5.6.    Latin America Multi-Modal Spatial Omics Platforms Market Revenue (US$ Million) Estimates and Forecasts by Spatial Resolution, 2021-2034
13.5.7.    Latin America Multi-Modal Spatial Omics Platforms Market Revenue (US$ Million) Estimates and Forecasts by Multiplexing Capacity, 2021-2034
13.5.8.    Latin America Multi-Modal Spatial Omics Platforms Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
13.5.9.    Latin America Multi-Modal Spatial Omics Platforms Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2021-2034

13.6.    Middle East & Africa 

13.6.1.    Middle East & Africa Wind Turbine Rotor Blade Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034

13.6.1.1.    GCC Countries
13.6.1.2.    Israel
13.6.1.3.    South Africa
13.6.1.4.    Rest of Middle East and Africa

13.6.2.    Middle East & Africa Multi-Modal Spatial Omics Platforms Market Revenue (US$ Million) Estimates and Forecasts by Multi-Omic Combination, 2021-2034
13.6.3.    Middle East & Africa Multi-Modal Spatial Omics Platforms Market Revenue (US$ Million) Estimates and Forecasts by Detection Modality, 2021-2034
13.6.4.    Middle East & Africa Multi-Modal Spatial Omics Platforms Market Revenue (US$ Million) Estimates and Forecasts by Workflow Component, 2021-2034
13.6.5.    Middle East & Africa Multi-Modal Spatial Omics Platforms Market Revenue (US$ Million) Estimates and Forecasts by Sample Type, 2021-2034
13.6.6.    Middle East & Africa Multi-Modal Spatial Omics Platforms Market Revenue (US$ Million) Estimates and Forecasts by Spatial Resolution, 2021-2034
13.6.7.    Middle East & Africa Multi-Modal Spatial Omics Platforms Market Revenue (US$ Million) Estimates and Forecasts by Multiplexing Capacity, 2021-2034
13.6.8.    Middle East & Africa Multi-Modal Spatial Omics Platforms Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
13.6.9.    Middle East & Africa Multi-Modal Spatial Omics Platforms Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2021-2034

Chapter 14.    Competitive Landscape

14.1.    Major Mergers and Acquisitions/Strategic Alliances
14.2.    Company Profiles

14.2.1.    10x Genomics
14.2.1.1.    Business Overview
14.2.1.2.    Key Multi-Omic Combination/Service Overview
14.2.1.3.    Financial Performance
14.2.1.4.    Geographical Presence
14.2.1.5.    Recent Developments with Business Strategy
14.2.2.    Vizgen 
14.2.3.    Miltenyi Biotec 
14.2.4.    Standard BioTools (Fluidigm) 
14.2.5.    Ionpath 
14.2.6.    Lunaphore (now part of Bio-Techne) 
14.2.7.    Bio-Techne / ACD 
14.2.8.    Curio Bioscience
14.2.9.    Akoya Biosciences
14.2.10.    Molecular Instruments (HCR) 
14.2.11.    Ultivue 
14.2.12.    Other prominent players

Research Design and Approach

This study employed a multi-step, mixed-method research approach that integrates:

  • Secondary research
  • Primary research
  • Data triangulation
  • Hybrid top-down and bottom-up modelling
  • Forecasting and scenario analysis

This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.

Secondary Research

Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.

Sources Consulted

Secondary data for the market study was gathered from multiple credible sources, including:

  • Government databases, regulatory bodies, and public institutions
  • International organizations (WHO, OECD, IMF, World Bank, etc.)
  • Commercial and paid databases
  • Industry associations, trade publications, and technical journals
  • Company annual reports, investor presentations, press releases, and SEC filings
  • Academic research papers, patents, and scientific literature
  • Previous market research publications and syndicated reports

These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.

Secondary Research

Primary Research

Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.

Stakeholders Interviewed

Primary interviews for this study involved:

  • Manufacturers and suppliers in the market value chain
  • Distributors, channel partners, and integrators
  • End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
  • Industry experts, technology specialists, consultants, and regulatory professionals
  • Senior executives (CEOs, CTOs, VPs, Directors) and product managers

Interview Process

Interviews were conducted via:

  • Structured and semi-structured questionnaires
  • Telephonic and video interactions
  • Email correspondences
  • Expert consultation sessions

Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.

Data Processing, Normalization, and Validation

All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.

The data validation process included:

  • Standardization of units (currency conversions, volume units, inflation adjustments)
  • Cross-verification of data points across multiple secondary sources
  • Normalization of inconsistent datasets
  • Identification and resolution of data gaps
  • Outlier detection and removal through algorithmic and manual checks
  • Plausibility and coherence checks across segments and geographies

This ensured that the dataset used for modelling was clean, robust, and reliable.

Market Size Estimation and Data Triangulation

Bottom-Up Approach

The bottom-up approach involved aggregating segment-level data, such as:

  • Company revenues
  • Product-level sales
  • Installed base/usage volumes
  • Adoption and penetration rates
  • Pricing analysis

This method was primarily used when detailed micro-level market data were available.

Bottom Up Approach

Top-Down Approach

The top-down approach used macro-level indicators:

  • Parent market benchmarks
  • Global/regional industry trends
  • Economic indicators (GDP, demographics, spending patterns)
  • Penetration and usage ratios

This approach was used for segments where granular data were limited or inconsistent.

Hybrid Triangulation Approach

To ensure accuracy, a triangulated hybrid model was used. This included:

  • Reconciling top-down and bottom-up estimates
  • Cross-checking revenues, volumes, and pricing assumptions
  • Incorporating expert insights to validate segment splits and adoption rates

This multi-angle validation yielded the final market size.

Forecasting Framework and Scenario Modelling

Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.

Forecasting Methods

  • Time-series modelling
  • S-curve and diffusion models (for emerging technologies)
  • Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
  • Price elasticity models
  • Market maturity and lifecycle-based projections

Scenario Analysis

Given inherent uncertainties, three scenarios were constructed:

  • Base-Case Scenario: Expected trajectory under current conditions
  • Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
  • Conservative Scenario: Slow adoption, regulatory delays, economic constraints

Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.

Name field cannot be blank!
Email field cannot be blank!(Use email format)
Designation field cannot be blank!
Company field cannot be blank!
Contact No field cannot be blank!
Message field cannot be blank!
1777
Security Code field cannot be blank!

Frequently Asked Questions

Multi-Modal Spatial Omics Platforms Market Size is valued at USD 174.23 Mn in 2024 and is predicted to reach USD 504.55Mn by the year 2034 at a 11.4% CAGR during the forecast period for 2025-2034.

10x Genomics, Bruker (NanoString assets), Vizgen, Miltenyi Biotec, Standard BioTools (Fluidigm), Ionpath, Lunaphore (now part of Bio-Techne), Bio-Techne / ACD, Curio Bioscience

Multi-modal spatial omics platforms market is segmented into multi-omic combination, detection modality, workflow component, sample type, spatial resolution, multiplexing level, application, and end-user.

North America is home to prestigious colleges and renowned research organisations like the National Institutes of Health, which create an atmosphere that is favourable for advances in spatial omics.

Report License Selection

Determine the Appropriate License for your Report

Get Sample Report Enquiry Before Buying